A02904 Summary:
BILL NO | A02904 |
  | |
SAME AS | SAME AS S04808 |
  | |
SPONSOR | Quart |
  | |
COSPNSR | Weprin, Carroll, Richardson |
  | |
MLTSPNSR | Tague |
  | |
Amd §§3216, 3221 & 4303, rpld §3216 sub§ (i) ¶31-a, §3221 sub§ (l) ¶¶7-a & 7-b, §4303 sub§§ (l-1) & (l-2), Ins L | |
  | |
Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders. |
A02904 Actions:
BILL NO | A02904 | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
01/28/2019 | referred to insurance | |||||||||||||||||||||||||||||||||||||||||||||||||
03/12/2019 | reported referred to codes | |||||||||||||||||||||||||||||||||||||||||||||||||
03/18/2019 | reported | |||||||||||||||||||||||||||||||||||||||||||||||||
03/21/2019 | advanced to third reading cal.152 | |||||||||||||||||||||||||||||||||||||||||||||||||
04/10/2019 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
04/10/2019 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
04/10/2019 | REFERRED TO INSURANCE | |||||||||||||||||||||||||||||||||||||||||||||||||
06/03/2019 | SUBSTITUTED FOR S4808 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/03/2019 | 3RD READING CAL.1142 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/03/2019 | PASSED SENATE | |||||||||||||||||||||||||||||||||||||||||||||||||
06/03/2019 | RETURNED TO ASSEMBLY | |||||||||||||||||||||||||||||||||||||||||||||||||
12/19/2019 | delivered to governor | |||||||||||||||||||||||||||||||||||||||||||||||||
12/31/2019 | signed chap.748 |
A02904 Committee Votes:
Cahill | Aye | Garbarino | Aye | ||||||
Cook | Aye | Hawley | Aye | ||||||
Pretlow | Aye | Blankenbush | Aye | ||||||
Rivera | Aye | Finch | Excused | ||||||
Cymbrowitz | Aye | Raia | Aye | ||||||
Lavine | Aye | Palmesano | Aye | ||||||
Steck | Aye | Byrne | Aye | ||||||
Dilan | Aye | ||||||||
Hunter | Aye | ||||||||
Simotas | Aye | ||||||||
Walker | Aye | ||||||||
Niou | Aye | ||||||||
Rosenthal | Aye | ||||||||
Stern | Aye | ||||||||
McDonald | Aye | ||||||||
Romeo | Aye | ||||||||
Jacobson | Aye | ||||||||
Lentol | Aye | Ra | Aye | ||||||
Schimminger | Aye | Giglio | Aye | ||||||
Pretlow | Aye | Montesano | Aye | ||||||
Cook | Aye | Morinello | Aye | ||||||
Cymbrowitz | Aye | Palumbo | Aye | ||||||
O'Donnell | Absent | Garbarino | Aye | ||||||
Lavine | Aye | ||||||||
Perry | Aye | ||||||||
Zebrowski | Aye | ||||||||
Abinanti | Aye | ||||||||
Weprin | Aye | ||||||||
Mosley | Aye | ||||||||
Hevesi | Aye | ||||||||
Fahy | Aye | ||||||||
Seawright | Aye | ||||||||
Rosenthal | Aye | ||||||||
Go to top
A02904 Floor Votes:
Yes
Abbate
Yes
Crespo
ER
Gantt
Yes
LiPetri
Yes
Perry
Yes
Simon
Yes
Abinanti
Yes
Crouch
Yes
Garbarino
Yes
Lupardo
Yes
Pheffer Amato
Yes
Simotas
Yes
Arroyo
Yes
Cruz
Yes
Giglio
Yes
Magnarelli
ER
Pichardo
Yes
Smith
Yes
Ashby
Yes
Cusick
Yes
Glick
Yes
Malliotakis
Yes
Pretlow
Yes
Smullen
Yes
Aubry
Yes
Cymbrowitz
No
Goodell
Yes
Manktelow
Yes
Quart
Yes
Solages
Yes
Barclay
Yes
Davila
Yes
Gottfried
Yes
McDonald
Yes
Ra
Yes
Stec
Yes
Barnwell
Yes
De La Rosa
Yes
Griffin
Yes
McDonough
Yes
Raia
Yes
Steck
Yes
Barrett
Yes
DenDekker
Yes
Gunther
Yes
McMahon
ER
Ramos
Yes
Stern
Yes
Barron
Yes
DeStefano
Yes
Hawley
Yes
Mikulin
Yes
Raynor
Yes
Stirpe
Yes
Benedetto
Yes
Dickens
Yes
Hevesi
Yes
Miller B
Yes
Reilly
Yes
Tague
ER
Bichotte
Yes
Dilan
Yes
Hunter
Yes
Miller MG
Yes
Reyes
Yes
Taylor
Yes
Blake
Yes
Dinowitz
Yes
Hyndman
ER
Miller ML
Yes
Richardson
Yes
Thiele
Yes
Blankenbush
Yes
DiPietro
Yes
Jacobson
ER
Montesano
Yes
Rivera
Yes
Titus
Yes
Brabenec
Yes
D'Urso
Yes
Jaffee
Yes
Morinello
ER
Rodriguez
Yes
Vanel
Yes
Braunstein
Yes
Eichenstein
Yes
Jean-Pierre
Yes
Mosley
Yes
Romeo
Yes
Walczyk
Yes
Bronson
Yes
Englebright
Yes
Johns
Yes
Niou
Yes
Rosenthal D
Yes
Walker
Yes
Buchwald
Yes
Epstein
Yes
Jones
ER
Nolan
Yes
Rosenthal L
Yes
Wallace
Yes
Burke
Yes
Fahy
Yes
Joyner
Yes
Norris
Yes
Rozic
Yes
Walsh
Yes
Buttenschon
Yes
Fall
Yes
Kim
Yes
O'Donnell
ER
Ryan
Yes
Weinstein
Yes
Byrne
Yes
Fernandez
Yes
Kolb
Yes
Ortiz
Yes
Salka
Yes
Weprin
Yes
Byrnes
Yes
Finch
Yes
Lalor
Yes
Otis
Yes
Santabarbara
Yes
Williams
Yes
Cahill
Yes
Fitzpatrick
Yes
Lavine
Yes
Palmesano
Yes
Sayegh
Yes
Woerner
Yes
Carroll
No
Friend
Yes
Lawrence
Yes
Palumbo
Yes
Schimminger
Yes
Wright
Yes
Colton
Yes
Frontus
Yes
Lentol
Yes
Paulin
Yes
Schmitt
Yes
Zebrowski
Yes
Cook
Yes
Galef
Yes
Lifton
Yes
Peoples-Stokes
Yes
Seawright
Yes
Mr. Speaker
‡ Indicates voting via videoconference
A02904 Memo:
Go to topNEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)   BILL NUMBER: A2904 SPONSOR: Quart
  TITLE OF BILL: An act to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medi- cations used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto   PURPOSE OR GENERAL IDEA OF BILL: To ensure uniformity across all health insurance plan policies regarding reasonable patient access to medication assisted treatment for substance abuse disorders   SUMMARY OF SPECIFIC PROVISIONS: Section 1 repeals subdivision 31-a of section 3216 of the insurance law and replaces it with a new subdivision to require health insurers to provide patient access, without prior authorization requirements, for initial and renewal prescriptions for buprenorphine and long-acting injectable naltrexone for the treatment of substance abuse disorders. Section 2 repeals paragraphs 7-a and 7-b of subsection (1) of section 3221 of the insurance law and adds a new paragraph 7-a to require health insurers to provide patient access, without prior authorization require- ments, for initial and renewal prescriptions for buprenorphine and long- acting injectable naltrexone for the treatment of substance abuse disor- ders. Section 3 repeals subsections (1-1) and (1-2) of section 4303 of the insurance law and adds a new subsection (1-1) to require health insurers to provide patient access, without prior authorization requirements, for initial and renewal prescriptions for buprenorphine and long-acting injectable naltrexone for the treatment of substance abuse disorders. Section 4 provides that this act will take effect on the 60th day after enactment.   JUSTIFICATION: New York is experiencing an unprecedented heroin and opioid epidemic that is ravaging communities across the state. According to the New York State Comptroller's Office, New York has experienced an increase in death rates due to opioid and heroin addiction that outpaces almost any other state where data is available. This bill builds upon measures enacted in 2016 to improve access to health insurance coverage for substance abuse treatment, including medi- cation assisted treatment. In 2016, prior authorization requirements were removed for buprenorphine and long- acting injectable naltrexone in the Medicaid program. The purpose of this bill is to establish parity for all consumers by ensuring that addicted persons with commercial insurance coverage can access medication assisted treatment as prescribed by their health care providers without unnecessary barriers.   PRIOR LEGISLATIVE HISTORY: 2017-2018: A7979 passed Assembly   FISCAL IMPLICATIONS: None   EFFECTIVE DATE: Sixty days after enactment
A02904 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 2904 2019-2020 Regular Sessions IN ASSEMBLY January 28, 2019 ___________ Introduced by M. of A. QUART -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph 31-a of subsection (i) of section 3216 of the 2 insurance law is REPEALED and a new paragraph 31-a is added to read as 3 follows: 4 (31-a) (A) No policy that provides medical, major medical or similar 5 comprehensive-type coverage and provides coverage for prescription drugs 6 for medication for the treatment of a substance use disorder shall 7 require prior authorization for an initial or renewal prescription for 8 all buprenorphine products, methadone or long acting injectable naltrex- 9 one for detoxification or maintenance treatment of a substance use 10 disorder except where otherwise prohibited by law. 11 (B) Coverage provided under this paragraph may be subject to copay- 12 ments, coinsurance, and annual deductibles that are consistent with 13 those imposed on other benefits within the policy. 14 § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221 of the 15 insurance law are REPEALED and a new paragraph 7-a is added to read as 16 follows: 17 (7-a) (A) Every policy that provides medical, major medical or similar 18 comprehensive-type large group coverage shall provide immediate coverage 19 for all buprenorphine products, methadone or long acting injectable 20 naltrexone without prior authorization for the detoxification or mainte- 21 nance treatment of a substance use disorder. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD01428-01-9A. 2904 2 1 (B) Coverage provided under this paragraph may be subject to copay- 2 ments, coinsurance, and annual deductibles that are consistent with 3 those imposed on other benefits within the policy. 4 § 3. Subsections (l-1) and (l-2) of section 4303 of the insurance law 5 are REPEALED and a new subsection (l-1) is added to read as follows: 6 (l-1) (A) Every contract that provides medical, major medical, or 7 similar comprehensive-type large group coverage shall provide immediate 8 coverage for all buprenorphine products, methadone or long acting 9 injectable naltrexone without prior authorization for the detoxification 10 or maintenance treatment of a substance use disorder. 11 (B) Coverage provided under this paragraph may be subject to copay- 12 ments, coinsurance, and annual deductibles that are consistent with 13 those imposed on other benefits within the policy. 14 § 4. This act shall take effect on the sixtieth day after it shall 15 have become a law.
A02904 LFIN:
  | NO LFIN |
A02904 Chamber Video/Transcript:
3-26-19 | Video (@ 00:24:09) | Transcript pdf | Transcript html |
4-10-19 | Video (@ 00:07:33) | Transcript pdf | Transcript html |